Granules India has received USFDA approval for their generic ADHD medication, Amphetamine extended-release tablets. The drug, ...

Bengaluru: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with a Voluntary ...

Granules India has secured tentative approval from the USFDA for its generic ADHD medication. This approval is for ...

Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic medication ...

Shares of Sun Pharmaceutical Industries Ltd. are trading 2.4% lower on Thursday, December 18, after the US Food and Drug ...

Granules India secures U.S. FDA tentative approval for its ADHD generic, enhancing access to critical therapy and expanding its generics portfolio.

The said product is a generic equivalent of ADZENYS XR-ODT, will be manufactured at Granules' US facility in Chantilly, ...

US pharma Viatris (Nasdaq: VTRS) has logged four regulatory milestones across its global pipeline, spanning a US Food and ...

Amneal Pharmaceuticals recently received U.S. FDA approvals for its generic versions of RESTASIS® (cyclosporine ophthalmic emulsion 0.05%) and PROAIR® HFA (albuterol sulfate inhalation aerosol 90 mcg) ...

Cosette Pharma announces US FDA approval and launch of first generic version of Cipro HC with 180 days Competitive Generic Therapy: Bridgewater, New Jersey Thursday, December 18, ...

Granules India received USFDA approval for their generic ADHD medication, Amphetamine extended-release tablets, which will be ...

Granules India receives USFDA approval for generic Amphetamine tablets for ADHD. Expands US portfolio & CNS presence. Market ...